Zepbound (tirzepatide) lowers blood pressure in most patients, mainly as a result of weight loss. In the SURMOUNT-1 ambulatory blood pressure substudy, 24-hour systolic blood pressure dropped by 7.4 to 10.6 mmHg compared to placebo, depending on dose. About 70% of that reduction tracks directly with weight loss, while the rest appears to come from effects independent of the scale.
There’s one detail most articles skip: Zepbound also raises resting heart rate slightly – typically 2 to 5 beats per minute. That’s a separate measurement from blood pressure, and it’s a known effect across the entire GLP-1 medication class, not a red flag on its own. This guide breaks down what the data actually shows, who’s at risk for the opposite effect (low blood pressure), and how to monitor safely while on treatment.
Key takeaways
- Zepbound (tirzepatide) reduced 24-hour systolic blood pressure by 7.4-10.6 mmHg versus placebo in the SURMOUNT-1 ambulatory monitoring substudy – a larger effect than typically seen with semaglutide.
- About 58% of tirzepatide-treated patients reached normal blood pressure (under 130/80 mmHg) by week 72, compared to 35% on placebo.
- Roughly 70% of the blood pressure benefit is explained by weight loss itself; the remaining effect appears to be weight-independent.
- Zepbound also raises resting heart rate by about 2-5 beats per minute – a known GLP-1 class effect, separate from blood pressure, and usually not a concern.
- The biggest risk for most patients isn’t high blood pressure – it’s blood pressure dropping too low, especially if you’re already on antihypertensive medication and losing weight quickly.
- If you take blood pressure medication, your doctor may need to adjust the dose as your weight drops. Never change your BP medication without medical guidance.
Does Zepbound lower blood pressure?
Yes, for most patients – and the clinical data here is more specific than “yes it helps.” The SURMOUNT-1 trial included a required ambulatory blood pressure monitoring (ABPM) substudy of 600 participants, who wore 24-hour blood pressure monitors at baseline and again at week 36.
The results, by dose:
| Zepbound dose | 24-hr systolic BP reduction vs placebo | Diastolic BP reduction | Weight loss at 36 weeks |
|---|---|---|---|
| 5 mg | -7.4 mmHg | -2.0 mmHg | 15.0% |
| 10 mg | -10.6 mmHg | ~-3.0 mmHg | 19.5% |
| 15 mg | -8.0 mmHg | ~-4.0 mmHg | 20.9% |
These reductions held steady across both day and nighttime readings, and applied regardless of age, sex, baseline BMI, or whether someone already had hypertension. By week 72 in the main SURMOUNT-1 trial, 58% of people on tirzepatide reached a normal blood pressure reading (under 130/80 mmHg), compared to 35% of those on placebo.
For comparison, semaglutide (Wegovy) typically produces a 3-5 mmHg systolic reduction in office-based readings – noticeably smaller than tirzepatide’s ambulatory monitoring results. Some of that gap reflects the larger average weight loss seen with tirzepatide, since Zepbound outperforms Wegovy on the scale as well.
Related reading: What dose of Zepbound is most effective for weight loss?
Why does weight loss lower blood pressure?
Carrying excess weight makes your heart work harder to pump blood through more tissue, which raises vascular resistance and, over time, blood pressure. As that weight comes off, resistance drops and blood pressure tends to follow.
Mediation analysis from SURMOUNT-1 found that weight loss explains about 68-70% of the systolic blood pressure improvement and around 71% of the diastolic improvement. The remaining benefit appears to come from other mechanisms – possibly improved insulin sensitivity, reduced inflammation, or direct effects on blood vessel function that aren’t fully understood yet.
This is also why the blood pressure benefit tends to build gradually rather than showing up immediately. It tracks your weight loss curve, becoming more pronounced as you move through dose escalation and lose more weight.
Can Zepbound raise your blood pressure?
For most people, no – the overall trend runs in the opposite direction. But a temporary increase isn’t unheard of, especially in the first few weeks of treatment. This early window is also when the body is adjusting to several changes at once: new fluid balance, changes in sodium handling, and the GI side effects that come with starting any GLP-1 medication.
If you notice your blood pressure creeping up shortly after starting Zepbound, it’s usually temporary and tends to resolve as your body adapts. That said, any persistent increase should be reported to your doctor rather than assumed to be normal.
The heart rate effect people confuse with blood pressure
This is where a lot of confusion happens. Zepbound reliably increases resting heart rate by about 2 to 5 beats per minute on average – some patients notice more, especially in the first several weeks. This is a well-documented effect across the entire GLP-1 drug class, not something unique to tirzepatide, and it is a completely separate measurement from blood pressure.
Feeling like your heart is beating a little faster after starting Zepbound is real and expected. It doesn’t mean your blood pressure is elevated – in fact, the two often move in opposite directions on this medication, with heart rate ticking up slightly while blood pressure trends down.
Watch for these signals that warrant a call to your doctor:
- Resting heart rate consistently above 100 bpm
- Palpitations that feel irregular, not just faster
- Chest pain, dizziness, or lightheadedness alongside the faster heart rate
- Heart rate changes that don’t settle after 4-6 weeks
Related reading: How to manage Zepbound side effects
What are the risks of low blood pressure on Zepbound?
For many patients, low blood pressure (hypotension) – not high blood pressure – is the more relevant risk to watch for, especially if you’re already taking antihypertensive medication. As Zepbound lowers your blood pressure through weight loss, a dose of blood pressure medication that was previously appropriate can become too strong, pushing you below a healthy range.
This risk compounds with a few other common early-treatment factors:
- Reduced fluid intake from appetite suppression, especially during the first few weeks
- GI side effects like nausea or diarrhea, which can affect hydration and electrolyte balance
- Rapid weight loss during dose escalation, when blood pressure changes can happen faster than medication adjustments catch up
Signs of low blood pressure include dizziness when standing, lightheadedness, fatigue, or fainting. If you experience these, contact your doctor – your blood pressure medication dose may need to come down as your weight comes down.
Can you take Zepbound if you already have high blood pressure?
Yes, in most cases. People with controlled hypertension were included in the SURMOUNT-1 trial and, as a group, saw meaningful blood pressure improvements alongside weight loss. Having high blood pressure is not a reason to avoid Zepbound – it may actually be one of the better reasons to consider it, given the medication’s documented cardiovascular benefits.
That said, starting Zepbound with hypertension requires proper medical oversight. Your doctor will want to:
- Review your current blood pressure medications before you start
- Set a monitoring schedule, especially through dose escalation
- Adjust your antihypertensive doses proactively as weight loss progresses, rather than waiting for symptoms
This is exactly the kind of ongoing coordination a telehealth weight loss provider can manage alongside your Zepbound prescription.
How to monitor your blood pressure while on Zepbound
Regular monitoring makes it much easier to catch problems – in either direction – before they become serious. A few practical habits:
- Check consistently, not randomly. Same time of day, same conditions (seated, rested for 5 minutes, same arm) gives you readings you can actually compare over time.
- Track alongside your dose changes. Blood pressure shifts most noticeably around dose increases. Logging readings next to your injection schedule helps you and your doctor spot patterns.
- Watch trends, not single readings. One high or low reading in isolation usually isn’t meaningful. A consistent trend over 1-2 weeks is what matters.
- Report both directions. Persistent readings above your target range and symptoms of low blood pressure (dizziness, lightheadedness) both deserve a call to your provider – don’t assume only high readings are worth mentioning.
The bottom line
Zepbound tends to lower blood pressure, with SURMOUNT-1’s ambulatory monitoring data showing reductions of 7.4-10.6 mmHg – a larger effect than what’s typically reported with semaglutide. Most of this benefit comes from weight loss itself, though some appears to be weight-independent. The heart rate increase some patients notice (2-5 bpm) is a separate, well-documented effect that shouldn’t be mistaken for a blood pressure problem.
The more relevant risk for many patients, especially those already on blood pressure medication, is the opposite: blood pressure dropping too low as weight comes off. This is exactly why medical supervision matters throughout treatment – not just at the start.
Have questions about starting Zepbound with high blood pressure or existing antihypertensive medication? Talk to a licensed Heally physician about a monitoring plan that fits your health history. Same-day online consultations available.
FAQ
Does Zepbound lower blood pressure?
Yes, for most patients. In the SURMOUNT-1 ambulatory blood pressure substudy, Zepbound (tirzepatide) reduced 24-hour systolic blood pressure by 7.4-10.6 mmHg compared to placebo, depending on dose. About 70% of this benefit is explained by weight loss, with the rest likely coming from other metabolic effects.
Does Zepbound raise your heart rate?
Yes, modestly. Zepbound typically increases resting heart rate by 2-5 beats per minute. This is a known effect across all GLP-1 medications and is separate from blood pressure – in fact, heart rate often rises slightly while blood pressure falls on this medication. Contact your doctor if your resting heart rate exceeds 100 bpm or you experience irregular palpitations.
Can Zepbound cause low blood pressure?
Yes, this is actually more common as a concern than high blood pressure, especially in people already taking blood pressure medication. As weight drops and blood pressure improves, a previously appropriate antihypertensive dose can become too strong. Dehydration from reduced appetite or GI side effects can also contribute. Watch for dizziness, lightheadedness, or fainting.
Can I take Zepbound if I have high blood pressure?
Yes, in most cases. Patients with controlled hypertension were included in Zepbound’s clinical trials and generally saw blood pressure improve alongside weight loss. Your doctor should review your current blood pressure medications before starting and monitor closely, since dosage adjustments are often needed as weight loss progresses.
How much does Zepbound lower blood pressure compared to Wegovy?
Tirzepatide (Zepbound) showed larger blood pressure reductions than semaglutide (Wegovy) in available trial data – a 7.4-10.6 mmHg drop in 24-hour ambulatory monitoring, compared to roughly 3-5 mmHg typically reported for semaglutide in office readings. Some of this gap likely reflects tirzepatide’s greater average weight loss.
When should I worry about blood pressure changes on Zepbound?
Report any blood pressure reading consistently outside your target range to your doctor, in either direction. Also flag symptoms like dizziness, lightheadedness, fainting (possible low blood pressure), or a resting heart rate above 100 bpm with chest pain or irregular palpitations. Isolated single readings are less concerning than a consistent trend over 1-2 weeks.
Sources
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
- de Lemos JA, et al. Tirzepatide reduces 24-hour ambulatory blood pressure in adults with BMI ≥27 kg/m²: SURMOUNT-1 ambulatory blood pressure monitoring substudy. Hypertension. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.123.22022
- Tirzepatide and cardiovascular outcomes: a narrative review of mechanisms, efficacy and implications for heart failure management. Endocrinol Diabetes Metab. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12824524/
- UT Southwestern Medical Center. Effects of tirzepatide on ambulatory blood pressure and heart rate. https://physicianresources.utswmed.org/news/effects-of-tirzepatide-on-ambulatory-blood-pressure-and-heart-rate
- U.S. Food and Drug Administration. Zepbound (tirzepatide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217806s013lbl.pdf
Medical disclaimer
This article is for informational purposes only and does not constitute medical advice. Zepbound (tirzepatide) is an FDA-approved prescription medication for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Always consult a qualified healthcare provider before starting any treatment, and never adjust blood pressure medication on your own. Individual results vary.
